JP2005505569A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505569A5
JP2005505569A5 JP2003528530A JP2003528530A JP2005505569A5 JP 2005505569 A5 JP2005505569 A5 JP 2005505569A5 JP 2003528530 A JP2003528530 A JP 2003528530A JP 2003528530 A JP2003528530 A JP 2003528530A JP 2005505569 A5 JP2005505569 A5 JP 2005505569A5
Authority
JP
Japan
Prior art keywords
xylometazoline
salt
ipratropium
acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003528530A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005505569A (ja
JP4500045B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2002/003828 external-priority patent/WO2003024433A2/en
Publication of JP2005505569A publication Critical patent/JP2005505569A/ja
Publication of JP2005505569A5 publication Critical patent/JP2005505569A5/ja
Application granted granted Critical
Publication of JP4500045B2 publication Critical patent/JP4500045B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003528530A 2001-09-18 2002-09-18 感冒の治療のための組成物 Expired - Lifetime JP4500045B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (3)

Publication Number Publication Date
JP2005505569A JP2005505569A (ja) 2005-02-24
JP2005505569A5 true JP2005505569A5 (enExample) 2005-12-15
JP4500045B2 JP4500045B2 (ja) 2010-07-14

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003528530A Expired - Lifetime JP4500045B2 (ja) 2001-09-18 2002-09-18 感冒の治療のための組成物

Country Status (20)

Country Link
US (2) US7652030B2 (enExample)
EP (2) EP1661570A3 (enExample)
JP (1) JP4500045B2 (enExample)
KR (1) KR100810872B1 (enExample)
CN (1) CN1290502C (enExample)
AT (1) ATE318601T1 (enExample)
BR (1) BRPI0212586B8 (enExample)
CA (1) CA2460140C (enExample)
DE (1) DE60209511T2 (enExample)
DK (1) DK1446119T3 (enExample)
EA (1) EA008165B1 (enExample)
ES (1) ES2259098T3 (enExample)
HU (1) HU226527B1 (enExample)
MX (1) MXPA04002500A (enExample)
NO (1) NO334441B1 (enExample)
NZ (1) NZ531792A (enExample)
PL (1) PL208686B1 (enExample)
PT (1) PT1446119E (enExample)
SI (1) SI1446119T1 (enExample)
WO (1) WO2003024433A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
CN1290502C (zh) * 2001-09-18 2006-12-20 丹麦奈科明有限公司 治疗普通感冒的组合物
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1713472A2 (en) * 2004-02-06 2006-10-25 MEDA Pharma GmbH & Co. KG Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
NZ555693A (en) * 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
WO2010112358A2 (de) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Verfahren zur beschichtung einer oberfläche eines bauteils
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
EA033013B1 (ru) 2014-05-07 2019-08-30 Бёрингер Ингельхайм Интернациональ Гмбх Контейнер, индикаторное устройство и небулайзер
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
EA032719B1 (ru) * 2014-12-24 2019-07-31 Ярдан-Галенски Лабораторий Д.Д. Назальная лекарственная форма против заложенности носа
MX383771B (es) * 2015-12-02 2025-03-14 Pablo Cortes Borrego Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137981T3 (es) * 1991-11-19 2000-01-01 Univ Virginia Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
JP3009924B2 (ja) 1992-12-09 2000-02-14 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 安定化医用エアーゾル溶液製剤
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
AU6878098A (en) * 1997-04-30 1998-11-24 Warner-Lambert Company Topical nasal antiinflammatory compositions
NZ505919A (en) * 1998-01-30 2002-10-25 Novartis Consumer Health S Nasal solutions
ME00838B (me) 1998-06-18 2008-09-29 Boehringer Ingelheim Pharmaceuticals Inc Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanci
WO2000078297A2 (de) * 1999-06-22 2000-12-28 Boehringer Ingelheim International Gmbh Stabile xylometazolin- und oxymetazolinlösung
CN1290502C (zh) * 2001-09-18 2006-12-20 丹麦奈科明有限公司 治疗普通感冒的组合物

Similar Documents

Publication Publication Date Title
JP2005505569A5 (enExample)
JP6505177B2 (ja) 鼻腔内デクスメデトミジン組成物およびその使用方法
EP0036145B1 (en) An orally administered drug form comprising a polar bioactive agent and an adjuvant
US8450339B2 (en) Compositions for treatment of common cold
JP2003504368A5 (enExample)
CN102892418A (zh) 含烟碱的药物组合物
JP2006506345A5 (enExample)
CN1350465A (zh) 基于抗胆碱能有效的化合物及β-模拟物的新颖药物组合物
US20070020330A1 (en) Compositions comprising azelastine and methods of use thereof
CA2540174A1 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
KR20180030953A (ko) 아젤라스틴을 포함하는 조성물 및 이의 사용 방법
JP2002519318A5 (enExample)
CN102470099A (zh) 儿童用奥洛他定鼻腔喷雾方案
JP2014521753A (ja) ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス
CN100594936C (zh) 改善透粘膜给药制剂的吸收的方法
JP2006505486A (ja) 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
WO2008013929A2 (en) Anti-migraine oral spray formulations and methods
CA2495275A1 (en) Aerosol formulation for inhalation comprising an anticholinergic agent
EP2978407B1 (en) Aqueous solution composition containing ipratropium and oxymetazoline
CN111936124A (zh) 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
SK12682003A3 (sk) Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu
KR20200121818A (ko) 비강내 에피네프린 제제 및 질환의 치료 방법
US20050222205A1 (en) Treatment of pain with ifendropil
WO2014158118A1 (en) Suspension composition containing ipratropium and oxymetazoline